Hemogenyx Pharmaceuticals (LSE:HEMO) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals Days Payable?

Hemogenyx Pharmaceuticals's average Accounts Payable for the six months ended in Dec. 2023 was £0.32 Mil. Hemogenyx Pharmaceuticals's Cost of Goods Sold for the six months ended in Dec. 2023 was £0.00 Mil.

The historical rank and industry rank for Hemogenyx Pharmaceuticals's Days Payable or its related term are showing as below:

LSE:HEMO' s Days Payable Range Over the Past 10 Years
Min: 51.39 Med: 69.54 Max: 262.83
Current: 73.35

During the past 9 years, Hemogenyx Pharmaceuticals's highest Days Payable was 262.83. The lowest was 51.39. And the median was 69.54.

LSE:HEMO's Days Payable is ranked worse than
65.19% of 724 companies
in the Biotechnology industry
Industry Median: 148.12 vs LSE:HEMO: 73.35

Hemogenyx Pharmaceuticals's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Hemogenyx Pharmaceuticals Days Payable Historical Data

The historical data trend for Hemogenyx Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemogenyx Pharmaceuticals Days Payable Chart

Hemogenyx Pharmaceuticals Annual Data

Trend

Feb15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

65.73

118.93

262.83

55.66

73.35

Hemogenyx Pharmaceuticals Semi-Annual Data
	Feb15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial												-	-	-	-	-

Competitive Comparison of Hemogenyx Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Hemogenyx Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemogenyx Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemogenyx Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Hemogenyx Pharmaceuticals's Days Payable falls into.

Hemogenyx Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hemogenyx Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.374	+	0.302)	/	2 )	/	1.682	*	365
=	0.338					/	1.682	*	365
=	73.35

Hemogenyx Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.329	+	0.302)	/	2 )	/	0	*	365 / 2
=	0.3155					/	0	*	365 / 2
=	N/A

Hemogenyx Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Hemogenyx Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemogenyx Pharmaceuticals (LSE:HEMO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

5HU:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.hemogenyx.com

Hemogenyx Pharmaceuticals PLC is a operator of a biotechnology company intended to focus on the discovery, development, and commercialization of novel therapies and treatments for blood diseases, like leukaemia and lymphoma. The company's technologies aim to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy, its three distinct products include an immunotherapy product for the treatment of relapsed/refractory acute myeloid leukaemia (AML) and patient conditioning, the bi-specific antibody, for the treatment of AML and a community-based rehabilitation / Biomedical engineering platform, enabling users to generate treatments for existing and emerging viral infections.

Hemogenyx Pharmaceuticals (LSE:HEMO) Headlines

No Headlines